CPhI & P-MEC China has launched the “E-Trade Season 2021” from March to June 2021 to provide the pharmaceutical industry with online learning and trading opportunities. One of the themed sessions, named Sino-India Pharmaceutical Exchange, will be focusing on Indian & Chinese pharma markets, with online learning and trading opportunities. The live stream webinar will […]

Now in its 3rd year, the Blood-Brain Barrier Summit is the industry’s definitive blood-brain barrier conference, focused exclusively on evaluating innovative approaches to tackling the single biggest challenge for CNS drug developers. Building on the success of last year’s meeting, this year’s program will uncover how leading companies and academics are working to enhance BBB penetration through the […]

Close the Clinical Gap, Discover the Next Generation of Microbiome-based Therapeutics, and Establish New Partnerships to Accelerate Your Research The advancing scientific and clinical landscape mixed with the high-quality audience that we bring together has made this the must attend conference for those translating microbiome science into clinically successful therapeutics. There is increased excitement around […]

Since the start of the 20th century, there have been three major waves of innovation in drug discovery. We are now at the start of a fourth wave, multispecific medicines, that will pave the way for new treatments aimed at thousands of disease targets currently viewed as “undruggable”. By inducing proximity between two or more proteins, multispecifics can […]

Returning to the digital stage this summer, the 2nd JAK Inhibitors Drug Development Summit brings you the only dedicated JAK inhibitor conference that will allow you to utilize the knowledge of the greatest minds and thought leaders within the realms of the JAK pathway across dermatology, rheumatology, gastroenterology, oncology and hematology. Focusing on optimized selectivity, […]

The 3rd Annual Cell Engager Summit is the only industry-led forum dedicated to developing multi-specific cell engaging therapies in liquid and solid tumor indications, accelerating early discovery innovation into the clinic. This forum comes at a critical point for the cell engager field as the success observed in the hematological field has not been obtained with solid […]

The inaugural ARDS Drug Development Summit will bring 60+ biopharma leaders together to discover how the rise of SARS-CoV-2 ARDS, emergence of novel targets, and the past 12 months of unprecedented global focus on ARDS research has transformed this graveyard of drug development failures into a starting point for the next generation of therapeutics addressing […]

The mRNA-Based Therapeutics Summit will unite the world leaders developing mRNA therapeutics to discuss learnings, challenges and future directions concerning translation and manufacturing of your novel mRNA modality. From mRNA vaccine development for infectious disease and oncology, effective mRNA gene therapies and novel delivery strategies, we bring to you an all-inclusive platform dedicated to accelerating successful translation of mRNA into a […]

The Non-Small Cell Lung Cancer (NSCLC) Drug Development Summit is the definitive industry-led forum for drug development in the largest solid tumor indication. This is a strategic conference designed to bring drug development teams together to address critical challenges surrounding therapeutic potency, tumor resistance and relapse and expanding the clinical utility of targeted and immuno-therapies, either in combination or […]

Develop & implement your practical roadmap to migrate your GxP regulated applications to the cloud with regulatory, security & partner selection guidance.  Establish robust documentation practices to maintain CFR 11 compliance, accurately assess data security risks for migrating to cloud infrastructure & select the right partner to ensure sustained continuous compliance. Nothing is more important […]

Returning digitally in 2021, the 2nd Annual Gene Therapy for Neurological Disorders Europe meeting will possibly be your last chance to attend a European meeting without the airmiles! Focusing on the industry’s challenges of developing and delivering gene therapies to the CNS and bringing fresh faces and emerging companies into the conversation, this is not one to miss […]

In-House Impact: Life Sciences is a new type of forum, designed for and by legal leaders in the Life Sciences, to help legal teams move from enterprise defenders to enablers of innovation and cross-functional competency. This conference isn’t just unique in offering an industry-specific platform for the most progressive legal leaders to maximize their own business value; it’s […]

In the fight against emerging coronavirus variants, the need for long-lasting immunity is greater than ever… which is why the field is looking beyond antibodies and turning to T cells. The Cell-Mediated Therapies for Infectious Disease Summit is the first industry-dedicated meeting to understand and stimulate the immune cell response to develop long term immune memory to […]

In the context of dramatically increasing food allergy incidence and a breakthrough approval in the field, the Next Generation Food Allergy Drug Development Summit will unite large pharma and innovative biotechs to overcome the unique drug development challenges involved in turning promising food allergy biologics into clinical and commercial realities. Join us to investigate the latest technological […]

The 2nd Gene Therapy Immunogenicity Summit is the industry’s definitive forum enabling you to better modulate, measure and predict immune response to your gene therapy candidate. In the context of ever-increasing gene therapy clinical activity and uncertainty around immunogenicity challenges, the Gene Therapy Immunogenicity Summit will unite large pharma and innovative biotechs to ensure that you’re up to speed on […]

Translating Scientific Findings of the Skin Microbiome into Commercially Viable Therapeutics & Cosmetic Products That Improve Skin Health With improvements in the tools and technologies that enable deeper analysis of the skin microbiome, the community’s understanding of the skin microbiome is becoming clearer. This has led to the development of a number of breakthrough dermatological, […]

The inaugural virtual Prostate Cancer Drug Development Summit lands at a crucial time as the first and only dedicated conference for large pharma, biotech and pioneering academics to unite under a common and ambitious goal of accelerating the practical discovery, translation, and clinical development of safe and effective treatments for prostate cancer. Here's a sneak peek of crucial topics […]

The excitement surrounding integrins has been growing over the past few years, culminating in recent clinical success, innovative biology and medicinal chemistry advancements blazing the way to tackle previously undruggable disease modalities through novel integrin targets The Integrin-Targeted Drug Discovery Summit is not just the first, but the only industry-driven event sharing pioneering advances, expert insights and exclusive updates on the field […]

The 2nd Annual Biomarkers for Alzheimer’s Disease Summit is the industry’s only digital forum dedicated to sharing innovations in identifying new novel biomarkers and solving the challenges of developing clinically validated biomarkers for the earlier detection and diagnosis of Alzheimer’s Disease that are predictive of outcome measures and accurately reflect a therapeutic effect on target engagement. […]

New this year, the Neuropathic Pain Therapeutics digital summit is the only meeting for large pharma, biotech and pioneering academics addressing the industry’s key challenges of understanding the underlying pathophysiology of neuropathic pain, identifying novel therapeutic targets for neuropathic pain and more! With an ageing global population and unabating opioid crisis, the clinical need for […]

With 5 currently approved PI3K inhibitors in the market, and countless investments, M&As and candidates entering the clinical stages, the PI3K pathways space has experienced significant growth in recent years. The inaugural PI3K Pathways Summit is the industry’s only definitive conference providing in depth exploration of the biochemical basis of the pathway, the successes and […]

Overcome Translational & Clinical Challenges to Develop Disease-Modifying Drugs for IPF, the Archetypal Fibrotic Disease. From Dissecting Mechanisms of Epithelial Dysfunction to Discovering Patient Reported Outcomes for More Meaningful Clinical Trials, Uncover Scientific Advancements & Actionable Insights to Optimize IPF Drug Development. Returning with a revitalized agenda including 25 brand new speakers, the hotly anticipated two-tracked […]

The CAR-TCR industry has started 2021 with a bang! With the 4th CAR-T gaining long-awaited approval, Bristol-Myers Squibb have stepped onto the commercial stage, and the CAR-TCR field continues to boom with excitement as the competition heats up. The current approved therapies have encountered significant difficulties in the commercial market. Cell Therapies come with a high […]

Cancer remains one of the most challenging diseases we face today. Standard treatment protocols (chemotherapy, radiotherapy, and surgical intervention) are often hampered by toxic side effects and concomitant malignancies. Vaccines offer a promising alternative to unleash the most powerful force against cancer: our own immune system! At the inaugural Next Generation Cancer Vaccine Development Summit […]

By bringing together the world’s leading Decentralized Clinical Trials thinkers, the 2nd Operationalize: Decentralized Clinical Trials Summit will clarify the complex issues through end-to-end remote, decentralized, and siteless clinical trial program operationalization. Through open discussion, sharing best-practice case studies, and removing the hypothetical: this meeting is your best chance to solve your challenges based on […]

SMi Group are delighted to introduce a free exclusive webinar taking place on 7th September 2021 at 3pm BST, hosted by Zeiss. Synopsis / Webinar Overview: The majority of pharmaceutical powders require a size <500 μm for ease of manufacture and biopharmaceutical performance. Powder behaviour of particles in this size-range spans cohesive to aeratable powders. […]

As part of SMi’s leading Injectables series, this year’s event will address the key drivers of the pre-filled syringes and combination products industry to give a comprehensive insight into the latest device innovations, regulatory updates and future insights for the coming year. With the global market for prefilled syringes estimated to exceed $9.7bn by 2025, […]

More companies and institutions than ever before are embarking on development of gene therapies in metabolic disease, and they are encountering unique challenges, from fine-tuning dosing to defining clinically relevant biomarkers. Gene Therapy for Metabolic Disorders will unite large pharma and innovative biotechs to collectively overcome translational drug development barriers to deliver on the transformative promise of gene therapy approaches for patients in need.  Incorporating in-depth insights into the leading […]

In the time since its discovery, CRISPR has rapidly become an established tool in the genomics toolbox. Now the question is: What next? The CRISPR 2.0 Summit is devoted to showcasing only the latest and greatest innovations by uncovering how the next generation of CRISPR tools are radically enhancing efficacy, minimizing off-target effects & enabling efficient delivery to […]

Sponsored by: Innerspace, Solo Containment and STERIS Co-Chairs: Richard Denk, Senior Consultant Aseptic Processing and Containment, SKAN AG James Drinkwater, Head of Aseptic Processing and Containment Special Interest Group, PHSS and Head of GMP Compliance, F Ziel GmbH Exploring Effective Strategies and New Regulations for Compliant Pharmaceutical Manufacturing The aseptic processing industry has seen many changes […]